A pilot exercise intervention to evaluate the role of cardiorespiratory fitness in modulating cardiotoxicity among childhood cancer survivors exposed to anthracycline therapy.
AI interpretation is pending for this paper.
Open original publication →What the AI sees
Not AI summarized yet.
Research significance
Pending deeper interpretation.
Source abstract
BACKGROUND: Childhood cancer survivors (CCS) often experience cancer treatment-related cardiotoxicity, leading to reduced cardiorespiratory fitness (CRF), an integrated marker of cardiovascular, respiratory, and musculoskeletal function. Furthermore, low CRF is a strong predictor of mortality. OBJECTIVE: This study investigates the effects of a 16-week aerobic exercise intervention on CRF changes, as measured by peak oxygen consumption (VO2peak) and parameters of cardiac structure and function by cardiac magnetic resonance imaging (CMR). METHODS: Anthracycline-treated CCS were enrolled > 2 years post-treatment and underwent cardiotoxicity risk stratification, cardiopulmonary stress test (CPET) to determine CRF, and CMR before and after a 16-week aerobic exercise intervention. The intervention consisted of individualized sessions performed 3–5 days per week, with duration progressively increasing from 15 to 45 min at 50–80% of age-predicted maximal heart rate. Exercise adherence and intensity were objectively measured throughout the intervention using a Fitbit tracker. Subclinical myocardial dysfunction was assessed by segmental strain abnormality, with specific focus on the number of segments showing peak circumferential strain magnitude (εcc) ≤ 10% and εcc ≤ 17%. Descriptive and comparative statistics, including Pearson’s correlation and chi-square/Fisher’s exact and Mann-Whitney tests, were performed using SAS 9.4, with significance set at p < 0.05. RESULTS: Forty-seven subjects (median age 22.0 years [IQR 8.5], 10–25 years), 57.4% male, and 75% white were enrolled. Thirty patients (63.8%) completed the exercise intervention, 56.7% male, and 83.3% white, with a median age of 24.0 years (IQR 9.8 years). Twenty participants (42.6%) met the predefined adherence criterion of achieving ≥ 100% of the prescribed fairly active plus very active minutes. There was no statistically significant change in VO₂peak (mL/kg/min) for the study cohort (median [IQR]: 34.0 [13.7] vs. 34.4 [13.3]; p = 0.76). Total active minutes were positively correlated with change in VO2peak (mL/kg/min) (r = 0.71, p < 0.005), and VO2peak (L/min) (r = 0.64, p = 0.03). VO2peak increased ≥ 1 mL/kg/min in 16/30 (53.3%) of subjects. These subjects labeled “responders”, demonstrated a median increase in VO2peak of 3.6 mL/kg/min and significant increase in right ventricular end diastolic volume index (p = 0.035), left ventricular stroke volume index (p = 0.014) and ejection fraction (EF) (p = 0.045). At baseline, 12 subjects met high-risk definition based on segmental strain abnormalities (i.e., ≥ 2 segments with εcc ≤ 10% or ≥ 9 segments ≤ 17%). High risk subjects showed significant improvement in εcc with a post-intervention reduction in number of segments ≤ 10% from 2.0 to 0.0 (p = 0.017). CONCLUSIONS: Overall CCS did not show a significant change in VO₂peak in response to a 16-week exercise intervention. Those with higher adherence to the exercise prescription were more likely to experience meaningful improvements in post-intervention VO2peak and improvement in CMR parameters of structure and function. Participants classified as high-risk, based on εcc abnormalities, derived the greatest benefit. TRIAL REGISTRATION: Retrospectively registered: https://classic.clinicaltrials.gov/ct2/show/NCT04036032 , Registration date: July 25, 2019.